financetom
Business
financetom
/
Business
/
Intrepid Potash Names Kevin S. Crutchfield as CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Intrepid Potash Names Kevin S. Crutchfield as CEO
Dec 2, 2024 6:40 AM

09:04 AM EST, 12/02/2024 (MT Newswires) -- Intrepid Potash ( IPI ) said Monday its board has named Kevin S. Crutchfield as chief executive officer and board director, effective immediately.

Crutchfield, with over 30 years of mining experience, most recently served as president and chief executive of Compass Minerals (CMP), according to Intrepid.

He succeeds Finance Chief Matt Preston, who served as acting principal executive officer during the search process, Intrepid said, adding Preston will remain the chief financial officer.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Cencora to Acquire Retina Consultants of America for $4.6 Billion in Cash
--Cencora to Acquire Retina Consultants of America for $4.6 Billion in Cash
Nov 6, 2024
07:45 AM EST, 11/06/2024 (MT Newswires) -- Price: 238.55, Change: +4.56, Percent Change: +1.95 ...
Honda Motor Fiscal H1 Earnings Fall, Revenue Rises; Fiscal 2025 Revenue Forecast Lifted
Honda Motor Fiscal H1 Earnings Fall, Revenue Rises; Fiscal 2025 Revenue Forecast Lifted
Nov 6, 2024
07:19 AM EST, 11/06/2024 (MT Newswires) -- Honda Motor ( HMC ) reported fiscal H1 earnings Wednesday of 103.25 Japanese yen ($0.67) per diluted share, down from 124.63 yen a year earlier. A single analyst polled by Capital IQ expected 149.80 yen. Sales revenue for the six months ended Sept. 30 was 10.798 trillion yen, up from 9.609 trillion yen...
Teva Pharmaceutical Q3 Non-GAAP Earnings, Net Revenue Rise; 2024 Outlook Updated
Teva Pharmaceutical Q3 Non-GAAP Earnings, Net Revenue Rise; 2024 Outlook Updated
Nov 6, 2024
07:43 AM EST, 11/06/2024 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) reported Q3 non-GAAP earnings Wednesday of $0.69 per diluted share, up from $0.60 a year earlier. Analysts polled by Capital IQ expected $0.66. Net revenue for the quarter ended Sept. 30 was $4.33 billion, up from $3.85 billion a year earlier. Analysts polled by Capital IQ expected...
How Trump's second administration affects business: Musk, tariffs and more
How Trump's second administration affects business: Musk, tariffs and more
Nov 6, 2024
(Updates with new headline) Nov 6 (Reuters) - Donald Trump's return to the White House after winning the Nov. 5 U.S. presidential election may reshape American business. Much depends on whom he appoints as deputies and cabinet members, including the role of Tesla CEO Elon Musk, and what tariffs he enacts. Following are some major issues and sectors to watch:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved